Familial thrombophilia: genetic risk factors and management
Open Access
- 1 July 1997
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 242 (S740) , 9-15
- https://doi.org/10.1111/joim.1997.242.s740.9
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Increased fetal loss in women with heritable thrombophiliaThe Lancet, 1996
- Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen componentsThe Lancet, 1995
- Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.Journal of Clinical Investigation, 1994
- Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutationThe Lancet, 1994
- Further evidence that activated protein C resistance can be misdiagnosed as inherited functional protein S deficiencyBritish Journal of Haematology, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Treatment of coumarin-induced skin necrosis with a monoclonal antibody purified protein C concentrateArchives of Dermatology, 1993
- Type I protein S deficiency and skin necrosisPublished by Oxford University Press (OUP) ,1990
- Congenital Protein C Deficiency and Venous ThromboembolismNew England Journal of Medicine, 1983
- Deficiency of protein C in congenital thrombotic disease.Journal of Clinical Investigation, 1981